Total Payments
$1,076
2024 Payments
$285.67
Companies
14
Transactions
38
Medicare Patients
1,868
Medicare Billing
$481,353
Payment Breakdown by Category
Food & Beverage$1,076 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,076 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $302.25 | 5 | $0 (2024) |
| ABBVIE INC. | $225.22 | 9 | $0 (2024) |
| Averitas Pharma Inc. | $154.75 | 3 | $0 (2024) |
| Lundbeck LLC | $88.97 | 4 | $0 (2024) |
| PFIZER INC. | $53.25 | 2 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $51.78 | 3 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $47.11 | 3 | $0 (2021) |
| Lilly USA, LLC | $34.15 | 2 | $0 (2023) |
| US WorldMeds, LLC | $30.17 | 2 | $0 (2020) |
| DePuy Synthes Sales Inc. | $22.09 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $285.67 | 11 | ABBVIE INC. ($161.88) |
| 2023 | $543.54 | 12 | Janssen Pharmaceuticals, Inc ($284.31) |
| 2022 | $58.96 | 3 | Lundbeck LLC ($36.87) |
| 2021 | $28.98 | 2 | Collegium Pharmaceutical, Inc. ($16.67) |
| 2020 | $26.20 | 2 | MERZ NORTH AMERICA, INC. ($13.89) |
| 2019 | $95.03 | 6 | Collegium Pharmaceutical, Inc. ($30.44) |
| 2018 | $22.27 | 1 | Merz North America, Inc. ($22.27) |
| 2017 | $15.62 | 1 | MERZ NORTH AMERICA, INC. ($15.62) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: PAIN | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.10 | General |
| Category: NEUROLOGY | ||||||
| 05/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $76.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neuroscience | ||||||
| 02/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neuroscience | ||||||
| 10/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Neuroscience | ||||||
| 09/27/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Musculoskeletal | ||||||
| 09/22/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: PAIN | ||||||
| 09/14/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $123.13 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Neuroscience | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $103.44 | General |
| Category: Neuroscience | ||||||
| 02/01/2023 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Neuroscience | ||||||
| 01/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: NEUROLOGY | ||||||
| 10/06/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 456 | 4,863 | $454,257 | $124,232 |
| 2022 | 19 | 475 | 4,895 | $479,588 | $133,479 |
| 2021 | 20 | 502 | 5,060 | $477,684 | $132,542 |
| 2020 | 23 | 435 | 4,285 | $391,935 | $91,100 |
Total Patients
1,868
Total Services
19,103
Medicare Billing
$481,353
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 412 | $113,300 | $39,371 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 244 | $90,524 | $30,001 | 33.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 13 | 907 | $44,525 | $14,719 | 33.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 192 | $35,032 | $9,763 | 27.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 13 | 568 | $33,415 | $6,956 | 20.8% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 13 | 169 | $25,287 | $4,992 | 19.7% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 41 | 113 | $15,368 | $4,496 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $13,200 | $3,933 | 29.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 42 | 116 | $19,024 | $3,324 | 17.5% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 35 | 102 | $16,014 | $2,195 | 13.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 14 | 26 | $5,382 | $1,847 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 21 | $3,326 | $1,087 | 32.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 17 | 21 | $1,605 | $532.22 | 33.2% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 13 | 708 | $7,080 | $440.53 | 6.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 36 | 276 | $4,140 | $219.62 | 5.3% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 13 | 174 | $6,960 | $176.57 | 2.5% |
| J3490 | Unclassified drugs | Office | 2023 | 11 | 124 | $124.00 | $96.72 | 78.0% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2023 | 13 | 665 | $19,950 | $81.99 | 0.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 331 | $122,801 | $41,684 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 302 | $83,050 | $29,614 | 35.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 12 | 826 | $40,548 | $13,636 | 33.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 172 | $31,383 | $9,096 | 29.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 13 | 669 | $39,357 | $8,357 | 21.2% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 34 | 126 | $17,136 | $5,391 | 31.5% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 13 | 171 | $25,587 | $5,275 | 20.6% |
About Dr. Kenneth Thunder, MD
Dr. Kenneth Thunder, MD is a Integrative Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518929967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Thunder, MD has received a total of $1,076 in payments from pharmaceutical and medical device companies, with $285.67 received in 2024. These payments were reported across 38 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,076).
As a Medicare-enrolled provider, Thunder has provided services to 1,868 Medicare beneficiaries, totaling 19,103 services with total Medicare billing of $481,353. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Integrative Medicine
- Other Specialties Family Medicine, Pain Medicine
- Location Reno, NV
- Active Since 04/03/2006
- Last Updated 10/01/2025
- Taxonomy Code 202D00000X
- Entity Type Individual
- NPI Number 1518929967
Products in Payments
- SPRAVATO (Drug) $302.25
- QUTENZA (Drug) $154.75
- UBRELVY (Drug) $147.44
- VYEPTI (Biological) $88.97
- QULIPTA (Drug) $77.78
- NURTEC ODT (Drug) $53.25
- XTAMPZA (Drug) $47.11
- XEOMIN (Biological) $36.16
- Xeomin (Biological) $35.42
- ORTHOVISC (Device) $22.09
- EMGALITY (Drug) $21.84
- AIMOVIG (Biological) $19.82
- Lucemyra/Lofexidine (Drug) $17.86
- SPRIX (Drug) $17.38
- Lucemyra (Drug) $12.31
- REYVOW (Drug) $12.31
- NEUROSTAR TMS THERAPY (Device) $9.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.